Johnson & Johnson to pay $8B in damages for Risperdal drug linked to female breast tissue in boys

A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.